What is ICU?
If you or a loved one have ever been hospitalized, you may have heard the term “ICU” thrown around. But what exactly is an ICU? Here you wil…
Shows whether an acetaminophen (paracetamol) level drawn 4 to 24 hours after the first tablet of an acute ingestion is on or above the treatment line for acetylcysteine.
| Result | Meaning |
|---|---|
| On or above the treatment line | Start acetylcysteine. |
| High-risk ingestion: above the high-risk line, or a reported dose of at least 30 g within 24 hours | An increased acetylcysteine dose may be warranted, in consultation with a poison center or clinical toxicologist; the literature is not enough to recommend a specific dose. The consensus defines high risk for acute ingestion only. |
| Below the treatment line | Acetylcysteine is not needed when the time of the first tablet is known and reliable. If the level is above 10 µg/mL, repeat it 4-6 hours after the first for an extended-release product (first level at 4-12 hours) or with anticholinergic or opioid effects. |
| Doses over 24 hours or more | Not plotted: a repeated supratherapeutic ingestion. Give acetylcysteine until stopping criteria are met if the level is above 20 µg/mL (about 132 µmol/L) or AST or ALT is abnormal. |
The 2023 consensus counts any ingestion period of less than 24 hours as acute, whatever the pattern, and plots the level from the time of the first tablet: the studies behind the nomogram enrolled any pattern of ingestion as long as the level was measured within 24 hours of the first tablet. Multiple ingestions over more than 24 hours are a repeated supratherapeutic ingestion, for which the nomogram is not used; this calculator treats a span of exactly 24 hours the same way.
The nomogram cannot be used for a level drawn less than 4 hours or more than 24 hours after the first tablet, or when the time of ingestion is unknown or unreliable; when the history is in doubt, the consensus advises giving acetylcysteine. The intravenous acetylcysteine label notes that the nomogram may underestimate risk with chronic alcohol use, malnutrition or drugs that induce CYP2E1, and that treatment should be considered for them even below the line.
Treatment line (µg/mL) = 150 × 2−(t − 4)/4 High-risk line (µg/mL) = 300 × 2−(t − 4)/4 µmol/L = µg/mL × 6.614
t is the time in hours since the first tablet, from 4 to 24; µg/mL is the same as mg/L. On the semilogarithmic chart both lines halve every 4 hours: the treatment line runs from 150 µg/mL (992 µmol/L) at 4 hours to 37.5 µg/mL at 12 hours and about 4.7 µg/mL at 24 hours, and the high-risk line from 300 µg/mL at 4 hours to about 9.4 µg/mL at 24 hours. The original 1975 line began at 200 µg/mL; the treatment line sits 25% below it and the high-risk line 50% above it.
The values plotted on the chart above, in µg/mL with µmol/L in brackets.
| Hours since the first tablet | Treatment line | High-risk line |
|---|---|---|
| 4 | 150 (992) | 300 (1984) |
| 6 | 106 (702) | 212 (1403) |
| 8 | 75 (496) | 150 (992) |
| 10 | 53 (351) | 106 (702) |
| 12 | 37.5 (248) | 75 (496) |
| 16 | 18.8 (124) | 37.5 (248) |
| 20 | 9.4 (62) | 18.8 (124) |
| 24 | 4.7 (31) | 9.4 (62) |
The nomogram comes from Rumack and Matthew’s 1975 analysis of acetaminophen poisoning. In 2023 a 21-member panel chosen by four North American toxicology societies (America’s Poison Centers, the American Academy of Clinical Toxicology, the American College of Medical Toxicology and the Canadian Association of Poison Control Centers) used a modified Delphi method to revise it: it set the 4-24 hour window for an acute ingestion and replaced the term “massive ingestion” with “high-risk ingestion”, shown as its own line on the nomogram. The revised nomogram is reproduced in the FDA-approved labeling of intravenous acetylcysteine (Acetadote).
If you or a loved one have ever been hospitalized, you may have heard the term “ICU” thrown around. But what exactly is an ICU? Here you wil…
You just received a call from the hospital that your loved one is admitted to ICU. This sounds scary. You already know what is ICU, but you…